4 - MultiPlan Corp (0001793229) (Issuer)

4 - MultiPlan Corp (0001793229) (Issuer)

4 - MultiPlan Corp (0001793229) (Issuer)

4 - MultiPlan Corp (0001793229) (Issuer)

4 - MultiPlan Corp (0001793229) (Issuer)

MultiPlan consolidates cloud infrastructure to establish a scalable foundation for growth, bring new products to market faster and better support its clients and the patients and members they serve with solutions that improve affordability, quality, and transparency. MultiPlan Corporation (NYSE:MPLN), a leading provider of technology and data solutions that improve affordability, quality and transparency in healthcare, will consolidate its cloud infrastructure on Oracle Cloud Infrastructure (OCI) to support its previously disclosed digital transformation. OCI will also help MultiPlan better support its clients' needs by improving efficiency and creating a more flexible infrastructure that

The partnership strengthens the distribution of solutions that unlock value and improve decision-making efficiency, supporting providers, payors, and the broader healthcare ecosystem MultiPlan Corporation ("MultiPlan" or the "Company") (NYSE:MPLN), a leading provider of technology and data solutions that improve affordability, quality and transparency in healthcare, today announced an agreement with J2 Health, a cloud-based software solution that optimizes provider network performance. This strategic agreement will support MultiPlan's network optimization strategy, providing tailored solutions and resource efficiency that ultimately reduces healthcare costs for payors. "J2 Health shares

MultiPlan Corporation (NYSE:MPLN) ("MultiPlan" or the "Company"), a leading provider of technology and data solutions focused on cost management, improving quality and transparency in healthcare, today announced a comprehensive refinancing to extend the maturities of its entire debt capital structure. "Our top priority is investing in our business to drive MultiPlan's organic growth. This refinancing extends our debt maturities and will ensure that our capital structure enables us to operate as efficiently and sustainably as possible," said Travis Dalton, Chief Executive Officer of MultiPlan. "We're grateful for the broad-based backing from investors who support our Vision 2030 transforma

Maturities extended for entire debt capital structure, with earliest funded maturity in 2030 and remainder in 2031 Refinancing enables continued investment in the business to support Vision 2030 transformation plan Broad based support from investors with participation from certain ad hoc groups of noteholders and lenders through a Transaction Support Agreement collectively representing nearly 78% of the Company's existing funded debt MultiPlan Corporation (NYSE:MPLN) ("MultiPlan" or the "Company"), a leading provider of technology and data solutions focused on cost management, improving quality and transparency in healthcare, today announced a comprehensive refinancing to extend t

This new platform provides enriched publicly available price transparency data to enable providers to gain actionable insights for improved strategic financial action. MultiPlan Corporation (NYSE:MPLN) ("MultiPlan" or the "Company"), a leading provider of data-driven cost management solutions that deliver transparency and promote fairness, quality and affordability to the U.S. healthcare industry, today announced the launch of CompleteVueTM, a modern software platform built using publicly available price transparency data that provides advanced analytics to help health systems and providers gain insight into the healthcare market. Recent legislation has brought incremental improvements

– Q3 2024 Revenues of $230.5 million, Net Loss of $391.5 million (including a $361.6 million impairment of goodwill and indefinite-lived intangibles), and Adjusted EBITDA of $141.6 million – Identified potential medical cost savings of approximately $6.4 billion in Q3 2024, up 10% from Q3 2023 and up 3% from Q2 2024 MultiPlan Corporation ("MultiPlan" or the "Company") (NYSE:MPLN), a leading provider of data-driven cost management solutions that deliver transparency and promote fairness, quality and affordability to the U.S. healthcare industry, today reported financial results for the third quarter ended September 30, 2024 and updated its full-year 2024 guidance. CEO Travis Dalton said,

MultiPlan Corporation (NYSE:MPLN), a leading provider of data-driven cost management solutions that deliver transparency and promote fairness, quality and affordability to the U.S. healthcare industry, is accepting applications for its Rural Health Grant now through December 15, 2024 from rural healthcare providers in the U.S. The grants provide financial resources to introduce or expand services, education, screenings and other programs aimed at improving the health of people in their communities. The MultiPlan Rural Health Grant is available to hospitals, rural health clinics and federally qualified health centers participating in any of MultiPlan's healthcare provider networks, includin

Tiffani Misencik Named Chief Growth Officer in New Executive Leadership Role MultiPlan Corporation ("MultiPlan" or the "Company") (NYSE:MPLN), a leading provider of data-driven cost management solutions that deliver transparency and promote fairness, quality and affordability to the U.S. healthcare industry, today announced a new addition to its executive leadership team to support the next phase of the Company's strategic growth. Tiffani Misencik has been appointed Chief Growth Officer. In this newly created role, Misencik will oversee MultiPlan's sales and revenue growth strategy across all market segments. She will lead the company's efforts in client acquisition, client management, an

MultiPlan Corporation ("MultiPlan" or the "Company") (NYSE:MPLN), a leading provider of data-driven cost management solutions that deliver transparency and promote fairness, quality and affordability to the U.S. healthcare industry, announced today that it will release its third quarter 2024 financial results on Tuesday, November 5, 2024, and hold its conference call that morning at 8:30 am Eastern Time. To join the conference call, please pre-register using the following link at least 10 minutes before the call begins: https://www.netroadshow.com/events/login?show=95da760a&confId=71678. Upon registration, you will receive an email with the conference dial-in details and a unique access co

Curren Katz Named Senior Vice President, Chief Data Science Officer Tara O'Neil Promoted to General Counsel; Scott Mays Promoted to SVP, Legal and Deputy General Counsel MultiPlan Corporation ("MultiPlan" or the "Company") (NYSE:MPLN), a leading provider of data-driven cost management solutions that deliver transparency and promote fairness, quality and affordability to the U.S. healthcare industry, today announced an addition to its leadership team and two internal promotions within its Legal team, showcasing the company's deep pool of talent. Curren Katz, PhD has been appointed Chief Data Science Officer. In this newly created role, Katz will lead and unify the company's efforts and ac

SCHEDULE 13D/A - MultiPlan Corp (0001793229) (Subject)

SCHEDULE 13G - MultiPlan Corp (0001793229) (Subject)

8-K - MultiPlan Corp (0001793229) (Filer)

8-K - MultiPlan Corp (0001793229) (Filer)

10-Q - MultiPlan Corp (0001793229) (Filer)

8-K - MultiPlan Corp (0001793229) (Filer)

8-K - MultiPlan Corp (0001793229) (Filer)

8-K - MultiPlan Corp (0001793229) (Filer)

8-K - MultiPlan Corp (0001793229) (Filer)

8-K - MultiPlan Corp (0001793229) (Filer)

Piper Sandler initiated coverage of MultiPlan with a rating of Neutral and set a new price target of $2.00

Citigroup downgraded MultiPlan from Buy to Neutral and set a new price target of $2.00 from $3.00 previously

Goldman initiated coverage of MultiPlan with a rating of Neutral and set a new price target of $6.50

Citigroup reiterated coverage of MultiPlan with a rating of Buy and set a new price target of $7.00 from $9.00 previously

Barclays reiterated coverage of MultiPlan with a rating of Equal-Weight and set a new price target of $6.00 from $7.00 previously

Citigroup resumed coverage of MultiPlan with a rating of Buy and set a new price target of $9.00

Tigress Financial initiated coverage of MultiPlan with a rating of Buy and set a new price target of $9.00

B. Riley FBR initiated coverage of MultiPlan with a rating of Buy and set a new price target of $10.00

Barclays initiated coverage of MultiPlan with a rating of Equal Weight and set a new price target of $7.00

Tiffani Misencik Named Chief Growth Officer in New Executive Leadership Role MultiPlan Corporation ("MultiPlan" or the "Company") (NYSE:MPLN), a leading provider of data-driven cost management solutions that deliver transparency and promote fairness, quality and affordability to the U.S. healthcare industry, today announced a new addition to its executive leadership team to support the next phase of the Company's strategic growth. Tiffani Misencik has been appointed Chief Growth Officer. In this newly created role, Misencik will oversee MultiPlan's sales and revenue growth strategy across all market segments. She will lead the company's efforts in client acquisition, client management, an

MultiPlan Corporation (NYSE:MPLN) ("MultiPlan" or the "Company"), a leading provider of technology and data-enabled cost management, payment, and revenue integrity solutions to the U.S. health care industry, is honored to announce it has been named in the 2024 Fortune Best Workplaces in Health Care™ List. based on its 2023-2024 Great Place to Work® Certification™ results. This is the second time MultiPlan has been named in the Best Workplaces in Health Care list. Earning a spot means that MultiPlan is one of the best companies to work for in the country. The Best Workplaces in Health Care list is based on analysis of survey responses from over 185,000 employees from Great Place To Work Cer

MultiPlan Corporation ("MultiPlan" or the "Company") (NYSE:MPLN), a leading value-added provider of data analytics and technology-enabled end-to-end cost management, as well as payment and revenue integrity solutions to the U.S. healthcare industry, announced today its CFO transition plan and named Doug Garis as EVP and CFO, effective August 5, 2024. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240731993142/en/Doug Garis named EVP and CFO of MultiPlan (Photo: Business Wire) Jim Head, who has served as EVP and CFO of MultiPlan since November 2021, will transition to a Strategic Advisor role to the Company through the end of the

MultiPlan Corporation (NYSE:MPLN) ("MultiPlan" or the "Company"), a leading value-added provider of data analytics and technology-enabled end-to-end cost management, as well as payment and revenue integrity solutions, to the U.S. healthcare industry, today announced that Great Place To Work® and Fortune magazine have recognized the Company as one of the Best Workplaces in New York™ for 2024. This marks the second consecutive year MultiPlan has been named to this prestigious list. "Our inclusion on this list makes clear the unwavering investment we make in our employees' long-term success," said Carol Nutter, SVP and Chief People Officer at MultiPlan. "MultiPlan prides itself on maintainin

Hogge's Growth-Driven Expertise Bolsters MultiPlan's Next Phase of Growth and Innovation MultiPlan Corporation (NYSE:MPLN) ("MultiPlan" or the "Company"), a leading value-added provider of data analytics and technology-enabled end-to-end cost management, as well as payment and revenue integrity solutions to the U.S. healthcare industry, today announced that Jerry Hogge will join the Company as Executive Vice President, Chief Operating Officer (COO). Hogge is a highly accomplished operational and commercial leader who has excelled within the healthcare and telecommunications industries for over 30 years. He has a wide range of experience driving operational efficiency and growth in compl

Transition Aligned with Company's Growth Strategy and Next Phase of Product Innovation MultiPlan Corporation (NYSE:MPLN) ("MultiPlan" or the "Company"), a leading value-added provider of data analytics and technology-enabled end-to-end cost management solutions to the U.S. healthcare industry, announced that Travis Dalton will join the Company as President and CEO on March 1, 2024. He will succeed Dale White, who will remain active as Executive Chair of the Company, succeeding current Chair Mark Tabak. With over 20 years in healthcare technology leadership positions at Cerner Corporation and Oracle Health, Mr. Dalton is a proven leader with deep experience in leveraging technology, data

Appointment of new SVP of Marketing and Communications and SVP of Products support the next phase of the Company's Growth Plan MultiPlan Corporation (NYSE:MPLN) ("MultiPlan" or the "Company"), a leading value-added provider of data analytics and technology-enabled end-to-end cost management, as well as payment and revenue integrity solutions to the U.S. healthcare industry, today announced the appointment of Melissa Humphrey to Senior Vice President of Marketing and Communications and the promotion of Andrea Rowe to Senior Vice President of Products. As MultiPlan's new SVP of Marketing and Communications, Humphrey will oversee the company's brand reputation, product marketing, client co

Adds significant payor industry expertise and bolsters next phase of company's growth plan MultiPlan Corporation (NYSE:MPLN) ("MultiPlan" or the "Company"), a leading provider of technology and data-enabled cost management, payment, and revenue integrity solutions to the U.S. healthcare industry, today announced the appointment of John Prince to its Board of Directors, effective June 26, 2023. Prince has more than 25 years of executive leadership experience running businesses in healthcare services and technology and managing enterprise functions spanning strategy, corporate development, operations, and technology for healthcare payors and providers, bringing a valuable depth of expertise

MultiPlan Corporation (NYSE:MPLN) ("MultiPlan" or the "Company"), a leading value-added provider of data analytics and technology-enabled end-to-end cost management solutions to the U.S. healthcare industry, today announced that Dale White will assume the title of Chief Executive Officer on February 1, 2022 in accordance with the Company's previously announced executive transition plan. Mr. White succeeds Mark Tabak. Since joining MultiPlan in 2004, Mr. White has held a variety of key leadership positions, most recently President and Chief Operating Officer. Along with his elevation to CEO, Mr. White has been appointed as a member of the Board of Directors and will serve as a Class III Dir

 Dr. Perryman to prioritize and operationalize data science opportunities across cost-management, payment, and revenue integrity solutions MultiPlan Corporation (NYSE:MPLN) a leading provider of data analytics and technology-enabled cost management, payment, and revenue integrity solutions to the U.S. healthcare industry, announces the appointment of Benjamin Perryman, PhD, to Vice President, Data Science Operations. In the new position, Dr. Perryman will implement an agile methodology focused on continuous delivery of client-centric analytical insights. Dr. Perryman's appointment is a part of MultiPlan's continued investment in systems and service infrastructure to support the delivery o

SC 13G/A - MultiPlan Corp (0001793229) (Subject)

SC 13G/A - MultiPlan Corp (0001793229) (Subject)

SC 13G/A - MultiPlan Corp (0001793229) (Subject)

SC 13G/A - MultiPlan Corp (0001793229) (Subject)

SC 13G/A - MultiPlan Corp (0001793229) (Subject)

SC 13G/A - MultiPlan Corp (0001793229) (Subject)

SC 13G/A - MultiPlan Corp (0001793229) (Subject)

SC 13G/A - MultiPlan Corp (0001793229) (Subject)

SC 13G/A - MultiPlan Corp (0001793229) (Subject)

SC 13D/A - MultiPlan Corp (0001793229) (Subject)

– Q3 2024 Revenues of $230.5 million, Net Loss of $391.5 million (including a $361.6 million impairment of goodwill and indefinite-lived intangibles), and Adjusted EBITDA of $141.6 million – Identified potential medical cost savings of approximately $6.4 billion in Q3 2024, up 10% from Q3 2023 and up 3% from Q2 2024 MultiPlan Corporation ("MultiPlan" or the "Company") (NYSE:MPLN), a leading provider of data-driven cost management solutions that deliver transparency and promote fairness, quality and affordability to the U.S. healthcare industry, today reported financial results for the third quarter ended September 30, 2024 and updated its full-year 2024 guidance. CEO Travis Dalton said,

MultiPlan Corporation ("MultiPlan" or the "Company") (NYSE:MPLN), a leading provider of data-driven cost management solutions that deliver transparency and promote fairness, quality and affordability to the U.S. healthcare industry, announced today that it will release its third quarter 2024 financial results on Tuesday, November 5, 2024, and hold its conference call that morning at 8:30 am Eastern Time. To join the conference call, please pre-register using the following link at least 10 minutes before the call begins: https://www.netroadshow.com/events/login?show=95da760a&confId=71678. Upon registration, you will receive an email with the conference dial-in details and a unique access co

– Q2 2024 Revenues of $233.5 million, Net Loss of $576.7 million (including a $553.7 million impairment of goodwill), and Adjusted EBITDA of $146.7 million – Identified potential medical cost savings of approximately $6.2 billion in Q2 2024, up 9% from Q2 2023 and up 8% from Q1 2024 – CFO transition plan announced MultiPlan Corporation ("MultiPlan" or the "Company") (NYSE:MPLN), a leading value-added provider of data analytics and technology-enabled end-to-end cost management, payment and revenue integrity solutions to the U.S. healthcare industry, today reported financial results for the second quarter ended June 30, 2024 and updated its full-year 2024 guidance. CEO Travis Dalton s

MultiPlan Corporation ("MultiPlan" or the "Company") (NYSE:MPLN), a leading value-added provider of data analytics and technology-enabled end-to-end cost management, as well as payment and revenue integrity solutions to the U.S. healthcare industry, announced today that it will release its second quarter 2024 financial results on Thursday, August 1, 2024, and hold its conference call that morning at 9:30 am Eastern Time. To join the conference call, please pre-register using the following link at least 10 minutes before the call begins: https://www.netroadshow.com/events/login?show=f096f8c3&confId=66913. Upon registration, you will receive an email with the conference dial-in details and

– Q1 2024 Revenues of $234.5 million, Net Loss of $539.7 million (including a $519.1 million impairment of goodwill and indefinite-lived intangible assets), and Adjusted EBITDA of $146.8 million – Identified potential medical cost savings of approximately $5.7 billion in Q1 2024, up 3% from Q1 2023 and down 3% from Q4 2023 – Repurchased or repaid $24.4 million of face value of debt, including $21.1 million of 6.0% Senior Convertible PIK Notes MultiPlan Corporation ("MultiPlan" or the "Company") (NYSE:MPLN), a leading value-added provider of data analytics and technology-enabled end-to-end cost management, payment and revenue integrity solutions to the U.S. healthcare industry, today r

MultiPlan Corporation ("MultiPlan" or the "Company") (NYSE:MPLN), a leading value-added provider of data analytics and technology-enabled end-to-end cost management, payment and revenue integrity solutions to the U.S. healthcare industry, announced today that it will release its first quarter 2024 financial results on Wednesday, May 8, 2024, and hold its conference call that morning at 8:00 am Eastern Time. Investors and analysts are encouraged to pre-register for the conference call by using the link below. Participants who pre-register will receive access details via email. Pre-registration may be completed at any time up to and following the start of the call. To pre-register, go to:

– Q4 2023 Revenues of $244.1 million, Net Loss of $31.4 million and Adjusted EBITDA of $156.8 million – Full Year 2023 Revenues of $961.5 million, Net Loss of $91.7 million and Adjusted EBITDA of $618.0 million – Identified potential medical cost savings of approximately $5.9 billion in Q4 2023, up 2.3% from Q3 2023 and up 9.4% from Q4 2022 – In Full Year 2023, the Company deployed cash of $140.9 million for the acquisition of Benefits Science LLC ("BST"), $165.8 million toward open-market debt repurchases and repayment, and $15.2 million toward share repurchases – Full Year 2024 Revenues guidance of $1,000 million to $1,030 million and FY 2024 Adjusted EBITDA guidance of $630 milli

MultiPlan Corporation ("MultiPlan" or the "Company") (NYSE:MPLN), a leading value-added provider of data analytics and technology-enabled end-to-end cost management, payment and revenue integrity solutions to the U.S. healthcare industry, announced today that it will release its fourth quarter and full year 2023 financial results on Thursday, February 29, 2024, and hold its conference call that morning at 8:00 am Eastern Time. Investors and analysts are encouraged to pre-register for the conference call by using the link below. Participants who pre-register will receive access details via email. Pre-registration may be completed at any time up to and following the start of the call. To

– Q3 2023 Revenues of $242.8 million, Net Loss of $24.1 million, and Adjusted EBITDA of $152.3 million – Identified potential medical cost savings of approximately $5.8 billion in Q3 2023, up 2% from Q2 2023 and up 7% from Q3 2022 – Repurchased an additional $46.1 million in face value of our 5.75% Senior Unsecured Notes in the open market in Q3 2023 MultiPlan Corporation ("MultiPlan" or the "Company") (NYSE:MPLN), a leading value-added provider of data analytics and technology-enabled end-to-end cost management, payment and revenue integrity solutions to the U.S. healthcare industry, today reported financial results for the third quarter ended September 30, 2023. "The third quarter

MultiPlan Corporation ("MultiPlan" or the "Company") (NYSE:MPLN), a leading value-added provider of data analytics and technology-enabled end-to-end cost management, payment and revenue integrity solutions to the U.S. healthcare industry, today announced that it will release its third quarter 2023 financial results on Tuesday, November 7, 2023, and hold its conference call that morning at 8:00 am Eastern Time. Investors and analysts are encouraged to pre-register for the conference call by using the link below. Participants who pre-register will receive access details via email. Pre-registration may be completed at any time up to and following the start of the call. To pre-register, go